AttendMe Owl Logo
AttendMe
Evidence Evolution
ENT / Head & Neck SurgeryENT / Head & Neck Surgery

How This Evidence Evolved

Thyroidectomy Extent for Low-Risk Cancer

Lobectomy, total thyroidectomy and active surveillance for selected thyroid cancers

29.4

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Proof

Landmark RCTs and pivotal trials that established the evidence base

Observation cohorts also examined low-risk papillary microcarcinoma. In Ito’s later cohort of 1,235 patients, none developed distant metastases or died of PTC during observation. Younger age was associated with progression. These findings support selection based on progression risk.
Extension

Follow-up studies, subgroup analyses, and real-world validation

Active surveillance expanded beyond Japan. Tuttle and colleagues studied 291 patients with low-risk intrathyroidal PTC ≤1.5 cm in a US cohort, using serial ultrasound measurements. During a median 25 months of surveillance, growth of ≥3 mm occurred in 11 patients (3.8%); no regional or distant metastases developed. Tumor-volume measurements identified growth earlier than diameter measurements. This work defined growth kinetics during surveillance and could help guide the timing of imaging and treatment.
Guidelines

Integration into clinical practice guidelines and recommendations

ATA
Now

Current standard of care and ongoing research directions

Thyroid cancer management is in a de-escalation paradigm. An adjusted NCDB cohort of 61,775 PTC patients found similar overall survival after total thyroidectomy and lobectomy (HR 0.96, 95% CI 0.84–1.09). A separate inpatient study found complications after 20.4% of total versus 10.8% of unilateral procedures. NIFTP refers to non-invasive encapsulated follicular-variant PTC and requires surgical excision for definitive diagnosis. In Ito’s selected observation cohort, none of 1,235 patients developed distant metastases or died of PTC during observation. How should surgery, surveillance, molecular findings, patient experience and radioiodine be integrated?

Landmark Trials in This Story

Bilimoria 20072007

Extent of surgery affects survival for papillary thyroid cancer

Recurrence and long-term survival by surgical extent

Ann SurgRetrospective cohort (NCDB)N=52,173
Hauch 20142014

Total thyroidectomy is associated with increased risk of complications for low- and high-volume surgeons.

Postoperative complications: total thyroidectomy 20.4% vs unilateral thyroidectomy 10.8% (P<0.0001); low- vs high-volume surgeon OR after total thyroidectomy 1.53 (95% CI 1.12–2.11; P=0.0083)

Ann Surg OncolNationwide Inpatient Sample cross-sectional analysisN=62,722
Adam 2014 NCDB2014

Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.

Overall survival at median 82-month follow-up: total thyroidectomy vs lobectomy (HR 0.96, 95% CI 0.84–1.09; P=.54)

Annals of surgeryAdjusted NCDB cohort analysisN=61,775
ATA 2015 Guidelines2016Landmark

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Treatment recommendations by risk stratification

Thyroid : official journal of the American Thyroid AssociationClinical practice guideline
Ito observation cohort 20032003

An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.

Tumor behavior during observation: >70% unchanged or smaller; lateral lymph-node metastasis 1.2% during follow-up

ThyroidNonrandomized observation cohortN=162
Ito observation cohort 20142014

Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.

Progression during observation (18–227 months): size enlargement, new nodal metastasis, or clinical disease; no distant metastasis or PTC death

ThyroidObservational cohortN=1,235
JAMA Otolaryngol Head Neck Surg 2017

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Tumor growth ≥3 mm during median 25-month surveillance: 11/291 patients (3.8%); no regional or distant metastases

JAMA Otolaryngol Head Neck SurgUS cohort study with serial ultrasonographyN=291
NIFTP review2017

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).

Non-invasive encapsulated FVPTC nomenclature and excision-based diagnosis

Journal of the American Society of CytopathologyNarrative review

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

Is lobectomy as safe as total thyroidectomy for low-risk thyroid cancer?+
An older NCDB study found no recurrence or survival difference below 1 cm, but higher risks with lobectomy at ≥1 cm. A later adjusted study of 61,775 PTC patients with 1–4 cm tumors found similar overall survival (HR 0.96, 95% CI 0.84–1.09; P=.54). Total versus unilateral thyroidectomy had more complications in a separate inpatient study (20.4% vs 10.8%; P<.0001).
What is active surveillance for thyroid microcarcinomas?+
Active surveillance uses serial ultrasound rather than immediate surgery in selected low-risk patients. Ito’s cohort of 1,235 patients underwent periodic ultrasound; none developed distant metastases or died of PTC during observation. In the US cohort of 291 patients with intrathyroidal tumors ≤1.5 cm, growth of ≥3 mm occurred in 3.8% during a median 25 months. No regional or distant metastases developed.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026